ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2026
Correlation Between Renal Biomarkers, Glomerular Filtration Rate, and Meropenem Clearance in Pediatric Septic Shock.
Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe primary objectives were to identify the correlation between various estimated glomerular filtration rate (eGFR) methods and observed meropenem clearance (CL
methodsWe prospectively assessed children aged 4 weeks to 21 years who received meropenem 20mg/kg IV every 8 hours from 2019 to 2023. Cases with sepsis were compared with controls without sepsis. Plasma meropenem concentrations and renal function biomarkers (serum creatinine [SCr], cystatin C [SCys]) were measured. GFR was estimated using: eGFR-MS (modified Schwartz for <18 years old and CKD-EPI for ≥ 18 years old), 3 equations by Pierce using SCr (eGFR-Cr) or SCys (eGFR-Cys) or their average (eGFR-Avg), and eGFR-Pot (Pottel).
resultsAnalysis included 27 subjects (n = 19 cases and n = 8 controls) with 309 meropenem serum concentrations. Median age was 11.8 (range 0.6-19.6) years, weight 36.3 (7.2-98.0) kg, CL
conclusionsThe renal function of critically ill children, especially with sepsis, was extremely diverse and variable by day. Current eGFR methods had weak correlation to CL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.